Company intelligence / Profile preview

Bold Health

London, England, United Kingdomboldhealthinc.com ↗

Ownership: Private
Employees: ~8
Development stage: Commercial

Overview

Bold Health provides a comprehensive virtual care platform for digestive health. Their programs combine telehealth with evidence-based digital therapeutics and multidisciplinary clinical support. The company has completed a clinical study with the University of Pennsylvania and holds CE Mark and MHRA certification for its solutions. It has launched pilots in the US market.

Therapeutic areas: Gastroenterology
Modalities: Non-pharmacological therapyDigital therapeutic program
Industry: Digital Health Medical Devices

Partnerships

University of Pennsylvania (clinical study collaboration)Self-insured employers and US health plans (as customers/pilots)CE Mark/MHRA regulatory partnershipsFive US pilot partners scheduled as of Q1 2022

Beyond the preview

Go deeper on Bold Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bold Health.

Explore the full profile